Home › Funds › Eversept Partners, LP › ABVX

Eversept Partners, LP position in ABVX

ABIVAX SA · Health Care

Eversept Partners, LP reported holding 913,880 shares of ABVX (ABIVAX SA) in its Q2 2026 13F filing — a position valued at US$121.8M, representing 6.37% of its reported portfolio and ranking #2 among its reported holdings. Eversept Partners, LP has disclosed ABVX holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)913.88K sh
Reported value held$121.78M
Portfolio Weight6.37%
First reportedQ3 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Eversept Partners, LP's ABVX position evolved

Eversept Partners, LP first disclosed a stake in ABVX in Q3 2025 at 426,499 shares (US$36.2M). The position peaked in Q2 2026 at 913,880 shares, worth US$121.8M. Across 4 filings, Eversept Partners, LP increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 913,880 shares valued at US$121.8M — a reduction of -20,543 shares quarter over quarter.. Notable position changes include a 54% increase in Q4 2025 (shares fell 17% over the following quarter), a 42% increase in Q1 2026 (shares rose 20% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 426.50K $36.21M New
Q4 2025 657.83K $88.71M Add
Q1 2026 934.42K $104.05M Add
Q2 2026 913.88K $121.78M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABVX and 13F data

ABVX (ABIVAX SA) is a Health Care company. 72 other funds we track also report a position in ABVX — the largest reported positions include TCG Crossover Management, LLC (US$800.6M), Helikon Investments Ltd (US$371.4M), Darwin Global Management, Ltd. (US$348.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABVX

All ABVX fund holders →

FAQ

How long has Eversept Partners, LP held ABVX?

Eversept Partners, LP has disclosed ABVX holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is Eversept Partners, LP's current position in ABVX?

As of Q2 2026, Eversept Partners, LP holds 913.88K shares of ABVX (ABIVAX SA), valued at $121.78M, representing 6.37% of its reported portfolio and ranking #2.

Has Eversept Partners, LP been buying or selling ABVX?

In the latest 13F filing (Q2 2026), Eversept Partners, LP reduced its position in ABVX. The position peaked in Q2 2026 at 913.88K shares.

Which other funds hold ABVX?

Other major institutional holders of ABVX include TCG Crossover Management, LLC, Helikon Investments Ltd, Darwin Global Management, Ltd., among 72 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.